This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Augusta Pharmaceuticals Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Dorre A Grueneberg: Innovator in Cancer Treatment
Introduction
Dorre A Grueneberg is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.
Latest Patents
Dorre A Grueneberg holds a patent for "Methods, compounds, and compositions for inhibition of ROS." This invention relates to a method utilizing novel compounds and compositions aimed at inhibiting ROS tyrosine kinase. Specifically, it covers a method to treat abnormal cell growth, such as cancer, using ROS inhibitors and compositions containing these inhibitors.
Career Highlights
Dorre A Grueneberg is associated with Augusta Pharmaceuticals Inc., where he has been instrumental in advancing research related to cancer therapies. His work focuses on developing effective treatments that target specific cellular mechanisms involved in cancer progression.
Collaborations
Dorre has collaborated with notable colleagues, including Ori Kalid and Jun Xian, to further enhance the research and development of innovative cancer treatments.
Conclusion
Dorre A Grueneberg's contributions to cancer treatment through his patented methods and compounds highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in medical therapies aimed at combating cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile